Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study

Autor:	Apostolia Maria Tsimberidou, Filip Janku, Jing Gong, Vivek Subbiah, Abdulrazzak Zarifa, Deby C. Ogbonna, Rivka R. Colen, Stacie Bean, Jatin P. Shah, Lacey McQuinn, Sarina Anne Piha-Paul, Aung Naing, Daniel D. Karp, Kyaw Zin Thein, Denái R. Milton, Brett W. Carter, Shubham Pant, Funda Meric-Bernstam
Rok vydání:	2021
Předmět:	Pharmacology Oncology medicine.medical_specialty business.industry Phase (waves) Single Center Internal medicine medicine Pharmacology (medical) In patient Topotecan Open label business medicine.drug
Zdroj:	Investigational New Drugs. 40:461-461
ISSN:	1573-0646 0167-6997
DOI:	10.1007/s10637-021-01192-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::864b7b2495e0437132cedfbf04a4a439 https://doi.org/10.1007/s10637-021-01192-5 Zobrazit plný text záznamu Full text from SpringerLink